NCT02581202View on ClinicalTrials.gov

The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

CompletedOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

December 21, 2015

Primary Completion Date

May 27, 2017

Study Completion Date

May 27, 2017

Conditions
HIV-1 Infection
Interventions
DRUG

lopinavir/ritonavir

tablet

DRUG

lamivudine

tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY